Ousmane Traoré

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial

Mehreen S. Datoo, Hamtandi Magloire Natama, Ousmane Traoré et al. · The Lancet · 2021 · 431 citations · Full text

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial

Mehreen S. Datoo, Alassane Dicko, Halidou Tinto et al. · The Lancet · 2024 · 296 citations · Full text

Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial

Mehreen S. Datoo, Hamtandi Magloire Natama, Duncan Bellamy et al. · The Lancet Infectious Diseases · 2022 · 268 citations

Vaccination, Clinical Malaria, Burkina Faso +8

CLEARANCE OF DRUG-RESISTANT PARASITES AS A MODEL FOR PROTECTIVE IMMUNITY IN PLASMODIUM FALCIPARUM MALARIA

Abdoulaye Djimdé, Ogobara K. Doumbo, Ousmane Traoré et al. · American Journal of Tropical Medicine and Hygiene · 2003 · 181 citations

Drug-resistant Parasites, Antiparasitic Agent, Malaria +16

Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy

Carlota Dobaño, Héctor Sanz, Hermann Sorgho et al. · Nature Communications · 2019 · 154 citations · Full text

Vaccination, Vaccine Development, Different Circumsporozoite Epitopes +13